Haemonetics to Acquire Cardiva Medical for ~$510M

 Haemonetics to Acquire Cardiva Medical for ~$510M

Haemonetics to Acquire Cardiva Medical for ~$510M

Shots:

  • Cardiva to receive $475M up front and up to an additional ~$35M in contingent consideration based on sales growth. The transaction is expected to be completed in Q1’21
  • The acquisition expands Haemonetics’ blood transfusion and loss management offerings and enhance its penetration into the large and growing interventional cardiology and electrophysiology markets
  • Cardiva’s portfolio includes two catheter-based vascular access site closure devices used to help seal up access sites following minimally invasive interventions and diagnostic procedures. Both devices employ a collapsible disc in different sizes to deliver a collagen patch to achieve hemostasis

Click here ­to­ read full press release/ article | Ref: PRNewswire| Image: Mass Device

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post